Pancreatic Cancer Research

Journal articleProc Natl Acad Sci U S A2013

Mutant KRAS is a druggable target for pancreatic cancer.

Journal
Proc Natl Acad Sci U S A
Published
2 December 2013
Citations
230
Type
Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try